To examine whether sPD-L1, sPD-1, and sCTLA-4 levels might be dependent on T cell–mediated immune reactions to cancer, we explored their relation to the number of CD8+ tumor-infiltrating lymphocytes (TILs) in cohort A. This evidence concerns the gene SPDL1 and neoplasm.